甲萘威

  • 基本信息
  • 制备方法及用途
  • 物化性质
  • 安全信息
  • 毒理性
  • MSDS
  • 海关数据
  • 结构与计算化学
  • 上游产品
  • 下游产品
  • 表征图谱

甲萘威 基本信息

中文名称:
甲萘威 
中文别名:
甲萘威;
西维因;
1-萘基-N-甲基氨基甲酸脂;
1-萘基-N-甲基氨基甲酸酯;
卡巴立;
胺甲萘;
虫卯酯 
英文名称:
carbaryl
英文别名:
carbaryl;
Carbaryl;
naphthalen-1-yl methylcarbamate;
NMC;
Sewin;
1-naphthyl methylcarbamate;
sevin;
1-naphthol N-methylcarbamate;
1-naphthalenyl N-methylcarbamate;
Mugan;
nmc50;
1-naphtalenol;
KARL;
Suleo;
carbaril;
SOK;
Pomex;
rylam;
naphth-1-yl N-methylcarbamate;
1-naphthalenyl methylcarbamate;
NAC 
CAS No.:
63-25-2
分 子 式:

C12H11NO2

分 子 量:
201.22
精确分子量:
201.07900
PSA:
38.33000
MDL:
MFCD00021467
EINECS:
200-555-0
BRN:
1875862
InChI:
InChI=1/C12H11NO2/c1-13(12(14)15)11-8-4-6-9-5-2-3-7-10(9)11/h2-8H,1H3,(H,14,15)/p-1
危险品标志:

HarmfulXnDangerousNFlammableF

风险术语:

R22;R40;R50;

安全术语:

S22;S24;S36/37;S46

分子结构式:
SDS:
查看

甲萘威 制备方法及用途

制备方法

(1)热法:将光气预热至90℃左右,甲胺预热至220℃,按摩尔比1:3:1调节流量进行酰氯化合成反应,该合成器上部温度控制在340~360℃,下部温度控制在240~280℃。控制反应气缓冲出口压力在0.1兆帕以下,酰氯受器和冷凝器夹套水温应严格控制。得到的甲氨基甲酰氯平均含量90%以上,收率83%以上。将甲萘酚和甲氨基甲酰氯以1:1.2的摩尔比投入缩合釜,搅拌反应。工艺过程可采用先将甲氨基甲酰氯溶于四氯化碳、氯苯、甲苯或其他溶剂中,再与甲萘酚反应;也可将其配的5%甲萘酚钠水溶液、3%氢氧化钠溶液及甲氨基甲酰氯溶液投入缩合釜,温度控制在10~15℃、pH8~11下连续反应,溢出的反应物经离心分离、水洗、干燥得甲萘威。 (2)冷法:将甲苯投入搪玻璃反应釜,再加入熔融的甲萘酚,搅拌冷却至-5℃以下,通入光气,同时滴加20%氢氧化钠溶液,反应维持在pH6~7,光化反应完成后,仍在-5℃下滴加一甲胺和氢氧化钠溶液,加完后搅拌保温2小时。将反应液过滤,回收滤液中的甲苯供循环使用,滤饼用稀盐酸和水洗滴,干燥,即得甲萘威,含量约95%,收率90%左右。 备注:对水、日光或热稳定,遇强碱分解成1-萘酚。对人畜毒性较小。对金属、包装材料和应用器械没有腐蚀性。在苹果、梨、白菜、西红柿中的最大允许残留量为5mg/kg,在高粱、桃、杏、蔬菜中则为10mg/kg。ADI为0.01mg/kg。安全间隔期10天。不能在养蜂区施药,以免蜜蜂中毒。对瓜类有药害。解毒药物为阿托品,但不要使用解磷定等肟类药物,治疗时要对症处理,及时控制肺水肿。 3.异氰酸甲酯的制备甲胺与光气在高温下直接进行气相反应,反应器为一管道。反应温度大于400℃,反应器材质为钢衬石墨。防止副产物生成以及杜绝反应器堵塞是生产中关键。异氰酸甲酯分离与精制系统主要设备是脱光气塔,精制异氰酸甲酯塔为90块塔板的浮阀塔,均采用高镍合金钢材料制造。 4.甲萘威的合成反应在溶剂存在下进行,温度60~80℃,稍有负压。生成的混合溶液通过蒸馏,将过量的异氰酸甲酯从蒸馏塔顶部与部分溶剂一起蒸出,再回复使用。甲萘威在溶液中经精制,得纯品。

合成制备方法

(1)热法:将光气预热至90℃左右,甲胺预热至220℃,按摩尔比1:3:1调节流量进行酰氯化合成反应,该合成器上部温度控制在340~360℃,下部温度控制在240~280℃。控制反应气缓冲出口压力在0.1兆帕以下,酰氯受器和冷凝器夹套水温应严格控制。得到的甲氨基甲酰氯平均含量90%以上,收率83%以上。将甲萘酚和甲氨基甲酰氯以1:1.2的摩尔比投入缩合釜,搅拌反应。工艺过程可采用先将甲氨基甲酰氯溶于四氯化碳、氯苯、甲苯或其他溶剂中,再与甲萘酚反应;也可将其配的5%甲萘酚钠水溶液、3%氢氧化钠溶液及甲氨基甲酰氯溶液投入缩合釜,温度控制在10~15℃、pH8~11下连续反应,溢出的反应物经离心分离、水洗、干燥得甲萘威。

(2)冷法:将甲苯投入搪玻璃反应釜,再加入熔融的甲萘酚,搅拌冷却至-5℃以下,通入光气,同时滴加20%氢氧化钠溶液,反应维持在pH6~7,光化反应完成后,仍在-5℃下滴加一甲胺和氢氧化钠溶液,加完后搅拌保温2小时。将反应液过滤,回收滤液中的甲苯供循环使用,滤饼用稀盐酸和水洗滴,干燥,即得甲萘威,含量约95%,收率90%左右。
备注:对水、日光或热稳定,遇强碱分解成1-萘酚。对人畜毒性较小。对金属、包装材料和应用器械没有腐蚀性。在苹果、梨、白菜、西红柿中的最大允许残留量为5mg/kg,在高粱、桃、杏、蔬菜中则为10mg/kg。ADI为0.01mg/kg。安全间隔期10天。不能在养蜂区施药,以免蜜蜂中毒。对瓜类有药害。解毒药物为阿托品,但不要使用解磷定等肟类药物,治疗时要对症处理,及时控制肺水肿。

3.异氰酸甲酯的制备甲胺与光气在高温下直接进行气相反应,反应器为一管道。反应温度大于400℃,反应器材质为钢衬石墨。防止副产物生成以及杜绝反应器堵塞是生产中关键。异氰酸甲酯分离与精制系统主要设备是脱光气塔,精制异氰酸甲酯塔为90块塔板的浮阀塔,均采用高镍合金钢材料制造。
4.甲萘威的合成反应在溶剂存在下进行,温度60~80℃,稍有负压。生成的混合溶液通过蒸馏,将过量的异氰酸甲酯从蒸馏塔顶部与部分溶剂一起蒸出,再回复使用。甲萘威在溶液中经精制,得纯品。

用途简介

1. 该品为氨基甲酸酯类杀虫剂,具有触杀、胃毒作用,微有内吸性质,能防治150多种作物的100多种害虫。可加工成可湿性粉剂或胶悬剂,用于防治水稻稻飞虱、稻叶蝉、棉花红铃虫、大豆食心虫和果树害虫。对有机氯,有机磷有抗性的昆虫有较好的防治效果。用药量一般为每公顷375-750g有效成分。该品不可与碱性农药混配使用。对蜜蜂毒性高,养蜂地区在开花季节不宜使用。 2. 高效、低毒、低残留、长残效的广谱性氨基甲酸酯类杀虫剂。对害虫有强烈的触杀作用,兼有胃毒作用,并有轻微的内吸作用。用于防治棉铃虫、卷叶虫、棉蚜、造桥虫、蓟马和稻叶蝉、稻纵卷叶螟、稻苞虫、稻蓟马及果树害虫,也可防治菜园蜗牛、蛞蝓等软体动物。常用剂量为2.6~20/100m2。

用途

1. 该品为氨基甲酸酯类杀虫剂,具有触杀、胃毒作用,微有内吸性质,能防治150多种作物的100多种害虫。可加工成可湿性粉剂或胶悬剂,用于防治水稻稻飞虱、稻叶蝉、棉花红铃虫、大豆食心虫和果树害虫。对有机氯,有机磷有抗性的昆虫有较好的防治效果。用药量一般为每公顷375-750g有效成分。该品不可与碱性农药混配使用。对蜜蜂毒性高,养蜂地区在开花季节不宜使用。

2. 高效、低毒、低残留、长残效的广谱性氨基甲酸酯类杀虫剂。对害虫有强烈的触杀作用,兼有胃毒作用,并有轻微的内吸作用。用于防治棉铃虫、卷叶虫、棉蚜、造桥虫、蓟马和稻叶蝉、稻纵卷叶螟、稻苞虫、稻蓟马及果树害虫,也可防治菜园蜗牛、蛞蝓等软体动物。常用剂量为2.6~20/100m2

甲萘威 物化性质

外观与性状:
无色至淡黄褐色的晶体
密度:
1.183 g/cm3
熔点:
142-146 °C(lit.)
沸点:
315°C
闪点:
202.7°C
水溶解性:
不溶. 0.00826 G/100 ML
存储条件/存储方法:
库房通风低温干燥,与氧化剂、碱类、食品添加剂分开存放
稳定性相关:

1. 对光、热和酸性物质较稳定,遇碱性物质易分解。在土壤微生物环境中易降解,生成-萘酚、-萘基-羧基-甲基氨基甲酸酯、-4-羟基-1-萘基-甲基氨基甲酸酯和5-羧基-1-萘基甲基氨基甲酸酯,其中1-萘基-羧基-甲基氨基甲酸酯可能致襄或致突变。

2. 存在于烟叶、烟气中。

3. 对人畜毒性较小。

 

其它信息:

1.       性状:纯品为白色结晶,工业品略带灰色或粉红色

2.       密度(g/mL,20/20℃):1.232

3.       相对蒸汽密度(g/mL,空气=1):不确定

4.       熔点(ºC):142

5.       沸点(ºC,常压):315

6.       沸点(ºC, 5.2kPa):不确定

7.       折射率:不确定

8.       闪点(ºC):202.7

9.       比旋光度(º):不确定

10.    自燃点或引燃温度(ºC):不确定

11.    蒸气压(Pa,25ºC):0.666

12.    饱和蒸气压(kPa,60ºC):不确定

13.    燃烧热(KJ/mol):不确定

14.    临界温度(ºC):不确定

15.    临界压力(KPa):不确定

16.    油水(辛醇/水)分配系数的对数值:不确定

17.    爆炸上限(%,V/V):不确定

18.    爆炸下限(%,V/V):不确定

19.    溶解性:二甲基甲酰胺>45%,丙酮>20%,环己酮>20%,甲乙酮>15%,氯仿>10%,乙醇>5%,甲苯>1%,水40mg/L(30℃)

甲萘威 安全信息

包装等级:
III
风险类别:
6.1(b)
海关代码:
2922499916
WGK_Germany:
3
德国有关水污染物质的分类清单
危险类别码:
R22;R40;R50
安全说明:
22-24-36/37-46-61-2-62-60
RTECS号:
FC5950000
安全标志:
S22:不要吸入粉尘。
S24:避免接触皮肤。
S46:万一发生不慎吞咽,立刻寻求医生的建议(展示产品容器或者标签)。
S61:避免排放到环境中。参考专门的说明/安全数据表。
:
危险标志:
Xn:Harmful

甲萘威 毒理性

CHEMICAL IDENTIFICATION

RTECS NUMBER :
FC5950000
CHEMICAL NAME :
Carbamic acid, methyl-, 1-naphthyl ester
CAS REGISTRY NUMBER :
63-25-2
BEILSTEIN REFERENCE NO. :
1875862
LAST UPDATED :
199712
DATA ITEMS CITED :
142
MOLECULAR FORMULA :
C12-H11-N-O2
MOLECULAR WEIGHT :
201.24
WISWESSER LINE NOTATION :
L66J BOVM1

HEALTH HAZARD DATA

ACUTE TOXICITY DATA

TYPE OF TEST :
Standard Draize test
ROUTE OF EXPOSURE :
Administration onto the skin
SPECIES OBSERVED :
Rodent - rabbit
TYPE OF TEST :
Standard Draize test
ROUTE OF EXPOSURE :
Administration into the eye
SPECIES OBSERVED :
Rodent - rabbit
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Human - man
DOSE/DURATION :
500 mg/kg
TOXIC EFFECTS :
Peripheral Nerve and Sensation - sensory change involving peripheral nerve Behavioral - muscle weakness
TYPE OF TEST :
LDLo - Lowest published lethal dose
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Human - woman
DOSE/DURATION :
5 gm/kg
TOXIC EFFECTS :
Autonomic Nervous System - parasympatholytic Cardiac - change in rate Nutritional and Gross Metabolic - other changes
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
230 mg/kg
TOXIC EFFECTS :
Biochemical - Enzyme inhibition, induction, or change in blood or tissue levels - true cholinesterase
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Administration onto the skin
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
4 gm/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Intraperitoneal
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
64 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Subcutaneous
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
1400 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Intravenous
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
18 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Unreported
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
500 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
128 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Intraperitoneal
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
25 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Subcutaneous
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
860 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Unreported
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
370 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Mammal - dog
DOSE/DURATION :
759 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Mammal - cat
DOSE/DURATION :
150 mg/kg
TOXIC EFFECTS :
Behavioral - convulsions or effect on seizure threshold Behavioral - muscle weakness Gastrointestinal - changes in structure or function of salivary glands
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Rodent - rabbit
DOSE/DURATION :
710 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Administration onto the skin
SPECIES OBSERVED :
Rodent - rabbit
DOSE/DURATION :
2 gm/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Intraperitoneal
SPECIES OBSERVED :
Rodent - rabbit
DOSE/DURATION :
223 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
TYPE OF TEST :
LD - Lethal dose
ROUTE OF EXPOSURE :
Subcutaneous
SPECIES OBSERVED :
Rodent - rabbit
DOSE/DURATION :
>2 gm/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Rodent - guinea pig
DOSE/DURATION :
250 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
TYPE OF TEST :
LC - Lethal concentration
ROUTE OF EXPOSURE :
Inhalation
SPECIES OBSERVED :
Rodent - guinea pig
DOSE/DURATION :
>390 mg/m3/4H
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
TYPE OF TEST :
LDLo - Lowest published lethal dose
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Rodent - hamster
DOSE/DURATION :
250 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Intraperitoneal
SPECIES OBSERVED :
Rodent - hamster
DOSE/DURATION :
640 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
TYPE OF TEST :
LDLo - Lowest published lethal dose
ROUTE OF EXPOSURE :
Subcutaneous
SPECIES OBSERVED :
Bird - chicken
DOSE/DURATION :
2 gm/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Bird - quail
DOSE/DURATION :
829 mg/kg
TOXIC EFFECTS :
Behavioral - convulsions or effect on seizure threshold Behavioral - ataxia Gastrointestinal - changes in structure or function of salivary glands
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Rodent - gerbil
DOSE/DURATION :
491 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Mammal - species unspecified
DOSE/DURATION :
510 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Unreported
SPECIES OBSERVED :
Mammal - species unspecified
DOSE/DURATION :
310 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Bird - wild bird species
DOSE/DURATION :
56 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
30 mg/kg/30D-I
TOXIC EFFECTS :
Liver - other changes Biochemical - Enzyme inhibition, induction, or change in blood or tissue levels - hepatic microsomal mixed oxidase (dealkylation, hydroxylation, etc.)
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
1050 mg/kg/21D-I
TOXIC EFFECTS :
Liver - other changes Blood - changes in serum composition (e.g. TP, bilirubin, cholesterol) Biochemical - Enzyme inhibition, induction, or change in blood or tissue levels - other oxidoreductases
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
10800 mg/kg/96D-C
TOXIC EFFECTS :
Liver - changes in liver weight Kidney, Ureter, Bladder - changes in bladder weight Nutritional and Gross Metabolic - weight loss or decreased weight gain
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
25480 mg/kg/1Y-I
TOXIC EFFECTS :
Endocrine - evidence of thyroid hypofunction Nutritional and Gross Metabolic - weight loss or decreased weight gain Biochemical - Enzyme inhibition, induction, or change in blood or tissue levels - true cholinesterase
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
1109 mg/kg/22W-I
TOXIC EFFECTS :
Biochemical - Enzyme inhibition, induction, or change in blood or tissue levels - phosphatases Biochemical - Enzyme inhibition, induction, or change in blood or tissue levels - phosphokinase Biochemical - Enzyme inhibition, induction, or change in blood or tissue levels - other Enzymes
TYPE OF TEST :
TCLo - Lowest published toxic concentration
ROUTE OF EXPOSURE :
Inhalation
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
214 ug/m3/24H/13W-I
TOXIC EFFECTS :
Brain and Coverings - recordings from specific areas of CNS Biochemical - Enzyme inhibition, induction, or change in blood or tissue levels - true cholinesterase Biochemical - Enzyme inhibition, induction, or change in blood or tissue levels - transaminases
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
720 mg/kg/10D-I
TOXIC EFFECTS :
Biochemical - Neurotransmitters or modulators (putative) - catecholamine levels in CNS Biochemical - Neurotransmitters or modulators (putative) - dopamine at other sites
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
300 mg/kg/50D-C
TOXIC EFFECTS :
Brain and Coverings - recordings from specific areas of CNS Brain and Coverings - other degenerative changes Biochemical - Metabolism (Intermediary) - other proteins
TYPE OF TEST :
TCLo - Lowest published toxic concentration
ROUTE OF EXPOSURE :
Inhalation
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
23 mg/m3/4H/17W-I
TOXIC EFFECTS :
Brain and Coverings - recordings from specific areas of CNS Behavioral - changes in motor activity (specific assay) Behavioral - alteration of classical conditioning
TYPE OF TEST :
TCLo - Lowest published toxic concentration
ROUTE OF EXPOSURE :
Inhalation
SPECIES OBSERVED :
Mammal - cat
DOSE/DURATION :
63 mg/kg/4W-I
TOXIC EFFECTS :
Biochemical - Enzyme inhibition, induction, or change in blood or tissue levels - true cholinesterase Related to Chronic Data - death
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Mammal - pig
DOSE/DURATION :
8157 mg/kg/72D-I
TOXIC EFFECTS :
Brain and Coverings - other degenerative changes Spinal Cord - other degenerative changes Musculoskeletal - other changes
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Bird - quail
DOSE/DURATION :
13230 mg/kg/14W-C
TOXIC EFFECTS :
Liver - changes in liver weight Kidney, Ureter, Bladder - changes in bladder weight Nutritional and Gross Metabolic - weight loss or decreased weight gain
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
5640 mg/kg/94W-I
TOXIC EFFECTS :
Tumorigenic - equivocal tumorigenic agent by RTECS criteria Gastrointestinal - tumors Skin and Appendages - tumors
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Implant
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
80 mg/kg
TOXIC EFFECTS :
Tumorigenic - Carcinogenic by RTECS criteria Skin and Appendages - tumors Tumorigenic - tumors at site of application
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Oral
DOSE :
1370 mg/kg
SEX/DURATION :
female 39 week(s) pre-mating
TOXIC EFFECTS :
Reproductive - Maternal Effects - menstrual cycle changes or disorders
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Oral
DOSE :
5500 mg/kg
SEX/DURATION :
multigenerations
TOXIC EFFECTS :
Reproductive - Fertility - other measures of fertility
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Oral
DOSE :
27500 ug/kg
SEX/DURATION :
multigenerations
TOXIC EFFECTS :
Reproductive - Effects on Newborn - live birth index (measured after birth) Reproductive - Effects on Newborn - growth statistics (e.g.%, reduced weight gain)
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Oral
DOSE :
220 mg/kg
SEX/DURATION :
female 5-15 day(s) after conception
TOXIC EFFECTS :
Reproductive - Effects on Newborn - weaning or lactation index (e.g., # alive at weaning per # alive at day 4)
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Oral
DOSE :
1370 mg/kg
SEX/DURATION :
male 39 week(s) pre-mating
TOXIC EFFECTS :
Reproductive - Paternal Effects - spermatogenesis (incl. genetic material, sperm morphology, motility, and count)
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Oral
DOSE :
5475 mg/kg
SEX/DURATION :
female 52 week(s) pre-mating
TOXIC EFFECTS :
Reproductive - Maternal Effects - ovaries, fallopian tubes Reproductive - Maternal Effects - uterus, cervix, vagina Reproductive - Effects on Newborn - live birth index (measured after birth)
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Oral
DOSE :
11660 mg/kg
SEX/DURATION :
female 6-15 day(s) after conception
TOXIC EFFECTS :
Reproductive - Effects on Embryo or Fetus - fetotoxicity (except death, e.g., stunted fetus)
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Oral
DOSE :
100 mg/kg
SEX/DURATION :
female 8 day(s) after conception
TOXIC EFFECTS :
Reproductive - Specific Developmental Abnormalities - musculoskeletal system Reproductive - Specific Developmental Abnormalities - urogenital system
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Oral
DOSE :
200 mg/kg
SEX/DURATION :
female 8 day(s) after conception
TOXIC EFFECTS :
Reproductive - Fertility - post-implantation mortality (e.g. dead and/or resorbed implants per total number of implants) Reproductive - Fertility - litter size (e.g. # fetuses per litter; measured before birth)
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Oral
DOSE :
150 mg/kg
SEX/DURATION :
female 8 day(s) after conception
TOXIC EFFECTS :
Reproductive - Specific Developmental Abnormalities - Central Nervous System Reproductive - Specific Developmental Abnormalities - eye/ear
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Subcutaneous
DOSE :
900 mg/kg
SEX/DURATION :
female 6-15 day(s) after conception
TOXIC EFFECTS :
Reproductive - Specific Developmental Abnormalities - Central Nervous System Reproductive - Specific Developmental Abnormalities - eye/ear Reproductive - Specific Developmental Abnormalities - musculoskeletal system
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Subcutaneous
DOSE :
900 mg/kg
SEX/DURATION :
female 6-14 day(s) after conception
TOXIC EFFECTS :
Reproductive - Effects on Embryo or Fetus - fetotoxicity (except death, e.g., stunted fetus)
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Subcutaneous
DOSE :
418 mg/kg
SEX/DURATION :
female 6-14 day(s) after conception
TOXIC EFFECTS :
Reproductive - Effects on Embryo or Fetus - extra-embryonic structures (e.g., placenta, umbilical cord)
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Subcutaneous
DOSE :
4176 mg/kg
SEX/DURATION :
female 6-14 day(s) after conception
TOXIC EFFECTS :
Reproductive - Effects on Embryo or Fetus - fetal death
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Oral
DOSE :
375 mg/kg
SEX/DURATION :
female 3-62 day(s) after conception
TOXIC EFFECTS :
Reproductive - Specific Developmental Abnormalities - body wall Reproductive - Specific Developmental Abnormalities - craniofacial (including nose and tongue) Reproductive - Specific Developmental Abnormalities - hepatobiliary system
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Oral
DOSE :
750 mg/kg
SEX/DURATION :
female 3-62 day(s) after conception
TOXIC EFFECTS :
Reproductive - Effects on Newborn - live birth index (measured after birth) Reproductive - Effects on Newborn - weaning or lactation index (e.g., # alive at weaning per # alive at day 4)
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Oral
DOSE :
197 mg/kg
SEX/DURATION :
female 1-63 day(s) after conception
TOXIC EFFECTS :
Reproductive - Fertility - post-implantation mortality (e.g. dead and/or resorbed implants per total number of implants) Reproductive - Effects on Newborn - stillbirth
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Oral
DOSE :
394 mg/kg
SEX/DURATION :
female 1-63 day(s) after conception
TOXIC EFFECTS :
Reproductive - Specific Developmental Abnormalities - musculoskeletal system Reproductive - Specific Developmental Abnormalities - gastrointestinal system
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Oral
DOSE :
1950 mg/kg
SEX/DURATION :
female 6-18 day(s) after conception
TOXIC EFFECTS :
Reproductive - Effects on Embryo or Fetus - fetotoxicity (except death, e.g., stunted fetus) Reproductive - Maternal Effects - other effects Nutritional and Gross Metabolic - weight loss or decreased weight gain
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Oral
DOSE :
2600 mg/kg
SEX/DURATION :
female 6-18 day(s) after conception
TOXIC EFFECTS :
Reproductive - Specific Developmental Abnormalities - body wall
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Oral
DOSE :
912 mg/kg
SEX/DURATION :
female 1-16 week(s) after conception
TOXIC EFFECTS :
Reproductive - Fertility - post-implantation mortality (e.g. dead and/or resorbed implants per total number of implants)
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Oral
DOSE :
300 mg/kg
SEX/DURATION :
female 12-16 day(s) after conception
TOXIC EFFECTS :
Reproductive - Specific Developmental Abnormalities - musculoskeletal system
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Oral
DOSE :
250 mg/kg
SEX/DURATION :
female 8 day(s) after conception
TOXIC EFFECTS :
Reproductive - Effects on Embryo or Fetus - fetal death
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Oral
DOSE :
12500 mg/kg
SEX/DURATION :
multigenerations
TOXIC EFFECTS :
Reproductive - Fertility - other measures of fertility
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Oral
DOSE :
20300 mg/kg
SEX/DURATION :
multigenerations
TOXIC EFFECTS :
Reproductive - Effects on Newborn - live birth index (measured after birth) Reproductive - Effects on Newborn - viability index (e.g., # alive at day 4 per # born alive) Reproductive - Effects on Newborn - weaning or lactation index (e.g., # alive at weaning per # alive at day 4)
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Oral
DOSE :
20300 mg/kg
SEX/DURATION :
multigenerations
TOXIC EFFECTS :
Reproductive - Fertility - female fertility index (e.g. # females pregnant per # sperm positive females; # females pregnant per # females mated)
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Oral
DOSE :
40600 mg/kg
SEX/DURATION :
multigenerations
TOXIC EFFECTS :
Reproductive - Effects on Newborn - growth statistics (e.g.%, reduced weight gain)
TYPE OF TEST :
Sex chromosome loss and nondisjunction
TYPE OF TEST :
Cytogenetic analysis
TYPE OF TEST :
Micronucleus test
TYPE OF TEST :
Sperm Morphology
TYPE OF TEST :
Sperm Morphology

MUTATION DATA

TYPE OF TEST :
Mutation in mammalian somatic cells
TEST SYSTEM :
Rodent - hamster Lung
REFERENCE :
CBINA8 Chemico-Biological Interactions. (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1969- Volume(issue)/page/year: 19,369,1977 *** REVIEWS *** ACGIH TLV-Not classifiable as a human carcinogen DTLVS* The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 Volume(issue)/page/year: TLV/BEI,1997 ACGIH TLV-TWA 5 mg/m3 DTLVS* The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 Volume(issue)/page/year: TLV/BEI,1997 IARC Cancer Review:Animal Inadequate Evidence IMEMDT IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- Volume(issue)/page/year: 12,37,1976 IARC Cancer Review:Human No Adequate Data IMEMDT IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- Volume(issue)/page/year: 12,37,1976 IARC Cancer Review:Group 3 IMSUDL IARC Monographs, Supplement. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) No.1- 1979- Volume(issue)/page/year: 7,56,1987 TOXICOLOGY REVIEW CNDQA8 Cahiers de Nutrition et de Dietetique. (Editions Meteore, 42, rue du Louvre, 75001 Paris, France) V.1- 1966- Volume(issue)/page/year: 10(3),43,1975 TOXICOLOGY REVIEW DTTIAF Deutsche Tieraerztliche Wochenschrift. (Hanover, Fed. Rep. Ger.) V.1-77, 1893-1970. Volume(issue)/page/year: 80,485,1973 TOXICOLOGY REVIEW RREVAH Residue Reviews. (Springer-Verlag New York, Inc., Service Center, 44 Hartz Way, Secaucus, NJ 07094) V.1- 1962- Volume(issue)/page/year: 63,1,1976 TOXICOLOGY REVIEW 85ALAU "Carbamate Insecticides: Chemistry, Biochemistry, and Toxicology," Kuhr, R.J., and H.W. Dorough, Cleveland, OH, CRC Press, 1976 Volume(issue)/page/year: -,106,1977 *** U.S. STANDARDS AND REGULATIONS *** EPA FIFRA 1988 PESTICIDE SUBJECT TO REGISTRATION OR RE-REGISTRATION FEREAC Federal Register. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) V.1- 1936- Volume(issue)/page/year: 54,7740,1989 MSHA STANDARD-air:TWA 5 mg/m3 DTLVS* The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 Volume(issue)/page/year: 3,37,1971 OSHA PEL (Gen Indu):8H TWA 5 mg/m3 CFRGBR Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) Volume(issue)/page/year: 29,1910.1000,1994 OSHA PEL (Construc):8H TWA 5 mg/m3 CFRGBR Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) Volume(issue)/page/year: 29,1926.55,1994 OSHA PEL (Shipyard):8H TWA 5 mg/m3 CFRGBR Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) Volume(issue)/page/year: 29,1915.1000,1993 OSHA PEL (Fed Cont):8H TWA 5 mg/m3 CFRGBR Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) Volume(issue)/page/year: 41,50-204.50,1994 *** OCCUPATIONAL EXPOSURE LIMITS *** OEL-ARAB Republic of Egypt:TWA 5 mg/m3 JAN 1993 OEL-AUSTRALIA:TWA 5 mg/m3 JAN 1993 OEL-AUSTRIA:TWA 5 mg/m3;Skin JAN 1993 OEL-BELGIUM:TWA 5 mg/m3 JAN 1993 OEL-DENMARK:TWA 5 mg/m3;Skin JAN 1993 OEL-FRANCE:TWA 5 mg/m3 JAN 1993 OEL-GERMANY:TWA 5 mg/m3;Skin JAN 1993 OEL-HUNGARY:STEL 1 mg/m3 JAN 1993 OEL-INDIA:TWA 5 mg/m3 JAN 1993 OEL-JAPAN:TWA 5 mg/m3;Skin JAN 1993 OEL-THE NETHERLANDS:TWA 5 mg/m3 JAN 1993 OEL-THE PHILIPPINES:TWA 5 mg/m3 JAN 1993 OEL-POLAND:TWA 1 mg/m3 JAN 1993 OEL-RUSSIA:STEL 1 mg/m3 JAN 1993 OEL-SWITZERLAND:TWA 5 mg/m3;Skin JAN 1993 OEL-THAILAND:TWA 5 mg/m3 JAN 1993 OEL-UNITED KINGDOM:TWA 5 mg/m3;STEL 10 mg/m3 JAN 1993 OEL IN BULGARIA, COLOMBIA, JORDAN, KOREA check ACGIH TLV OEL IN NEW ZEALAND, SINGAPORE, VIETNAM check ACGIH TLV *** NIOSH STANDARDS DEVELOPMENT AND SURVEILLANCE DATA *** NIOSH RECOMMENDED EXPOSURE LEVEL (REL) : NIOSH REL TO CARBARYL-air:10H TWA 5 mg/m3;min expos during pregnancy REFERENCE : NIOSH* National Institute for Occupational Safety and Health, U.S. Dept. of Health, Education, and Welfare, Reports and Memoranda. Volume(issue)/page/year: DHHS #92-100,1992 NIOSH OCCUPATIONAL EXPOSURE SURVEY DATA : NOHS - National Occupational Hazard Survey (1974) NOHS Hazard Code - 47800 No. of Facilities: 678 (estimated) No. of Industries: 5 No. of Occupations: 16 No. of Employees: 14120 (estimated) NOES - National Occupational Exposure Survey (1983) NOES Hazard Code - 47800 No. of Facilities: 2381 (estimated) No. of Industries: 5 No. of Occupations: 4 No. of Employees: 16544 (estimated) No. of Female Employees: 3228 (estimated)
毒理学数据:

雄性大鼠急性经口LD50为800mg /kg ,雌性为500 mg /kg。雄性大鼠急性经皮LD50> 4000mg/kg,兔大于2000mg/kg。以含有200mg /kg的词料喂养大鼠2年,没有出现不良反应。对鲤鱼LC50 > 10mg/L (48h),蝉鱼LC50为1 .95mg几(96h)。对野鸭急性经日LD50> 2000mg/kg。对蜜蜂毒性较大。

甲萘威 MSDS

第一部分:化学品名称
化学品中文名称: 西维因粉剂;1-萘基-N-甲基氨基甲酸酯
化学品英文名称: Sevin powder;1-Naphthyl-N-methyl carbamate
中文俗名或商品名:  
Synonyms:  
CAS No.: 63-25-2
分子式: C12H11NO2
分子量: 201.22
第二部分:成分/组成信息
             纯化学品   混合物
             化学品名称:西维因粉剂;1-萘基-N-甲基氨基甲酸酯
有害物成分 含量 CAS No.
西维因粉剂 100 63-25-2
第三部分:危险性概述
危险性类别: 第6.1类 毒害品
侵入途径: 吸入 食入 经皮吸收
健康危害: 主要是抑制胆碱酯酶,使乙酰胆碱在组织中蓄积。主要症状为流涎、恶心、流泪、瞳孔缩小、视力模糊、痉挛等。其抑制胆碱酯酶的作用持续时间较短,停止接触后,胆碱酯酶恢复较快。
环境危害:  
燃爆危险: 本品可燃,有毒。
危险特性: 5.12 遇明火、高热易引起燃烧。
  5.71 受热分解放出有毒气体。
  5.108 有毒,遇明火能燃烧。
危险性概述: A198 有毒、可燃
安全措施: B04 远离热源、火种,贮于阴凉通风处
  B09 贮于阴凉、通风、干燥处
  B51 应与氧化剂、碱类、食用化学品分储
  B77 眼睛接触,用流动清水彻底冲洗
  B82 误食,饮水,催吐,洗胃,导泄,就医
第四部分:急救措施
皮肤接触: 立即脱去污染的衣着,用肥皂水及流动清水彻底冲洗污染的皮肤、头发、指甲等。就医。
眼睛接触: 立即提起眼睑,用流动清水冲洗10分钟或用2%碳酸氢钠溶液冲洗。
吸入: 迅速脱离现场至空气新鲜处。呼吸困难时给输氧。呼吸停止时,立即进行人工呼吸。就医。
食入: 饮足量温水,催吐。洗胃,导泄。就医。。
第五部分:消防措施
危险特性: 遇明火、高热可燃。与强氧化剂可发生反应。受热分解放出有毒的氧化氮烟气。
有害燃烧产物: 一氧化碳、二氧化碳、氧化氮。
灭火方法及灭火剂: 雾状水、泡沫、二氧化碳、砂土。
消防员的个体防护: 消防人员须佩戴防毒面具、穿全身消防服,在上风向灭火。
禁止使用的灭火剂:  
闪点(℃): 无资料
自燃温度(℃): 无资料
爆炸下限[%(V/V)]: 无资料
爆炸上限[%(V/V)]: 无资料
最小点火能(mJ):  
爆燃点:  
爆速:  
最大燃爆压力(MPa):  
建规火险分级:  
第六部分:泄漏应急处理
应急处理: 隔离泄漏污染区,周围设警告标志,建议应急处理人员戴好防毒面具,穿化学防护服。不要直接接触泄漏物,避免扬尘,用清洁的铲子收集于干燥净洁有盖的容器中,运至废物处理场所。如大量泄漏,收集回收或无害处理后废弃。
第七部分:操作处置与储存
操作注意事项: 密闭操作,提供充分的局部排风。操作尽可能机械化、自动化。操作人员必须经过专门培训,严格遵守操作规程。建议操作人员佩戴自吸过滤式防尘口罩,戴化学安全防护眼镜,穿防毒物渗透工作服,戴乳胶手套。远离火种、热源,工作场所严禁吸烟。使用防爆型的通风系统和设备。避免产生粉尘。避免与氧化剂、碱类接触。搬运时要轻装轻卸,防止包装及容器损坏。配备相应品种和数量的消防器材及泄漏应急处理设备。倒空的容器可能残留有害物。
储存注意事项: 储存于阴凉、通风的库房。远离火种、热源。应与氧化剂、碱类、食用化学品分开存放,切忌混储。配备相应品种和数量的消防器材。储区应备有合适的材料收容泄漏物。
第八部分:接触控制/个体防护
最高容许浓度: 中国MAC:未制定标准苏联MAC:1mg/m3美国TWA:ACGIH 5mg/m3美国S
监测方法:  
工程控制: 严加密闭,提供充分的局部排风。尽可能机械化、自动化。提供安全淋浴和洗眼设备。
呼吸系统防护: 生产操作或农业使用时,佩带防毒口罩。紧急事态抢救或逃生时,应该佩带自给式呼吸器。
眼睛防护: 戴安全防护眼镜。
身体防护: 穿相应的防护服。
手防护: 戴防护手套。
其他防护: 工作现场禁止吸烟、进食和饮水。工作后,彻底清洗。工作服不要带到非作业场所,单独存放被毒物污染的衣服,
第九部分:理化特性
外观与性状: 白色结晶,工业品略带灰色或粉红色。
pH:  
熔点(℃): 145
沸点(℃): 无资料
相对密度(水=1): 1.23
相对蒸气密度(空气=1): 无资料
饱和蒸气压(kPa): 无资料
燃烧热(kJ/mol):  
临界温度(℃):  
临界压力(MPa):  
辛醇/水分配系数的对数值: 无资料
闪点(℃): 无资料
引燃温度(℃): 无资料
爆炸上限%(V/V): 无资料
爆炸下限%(V/V): 无资料
分子式: C12H11NO2
分子量: 201.22
蒸发速率:  
粘性:  
溶解性: 不溶于水,溶于乙醇、苯、丙酮等多数有机溶剂。
主要用途: 用作杀虫剂。
第十部分:稳定性和反应活性
稳定性: 在常温常压下 稳定
禁配物: 强氧化剂、强碱。
避免接触的条件:  
聚合危害: 不能出现
分解产物: 一氧化碳、二氧化碳、氧化氮。
第十一部分:毒理学资料
急性毒性: 属中等毒类 LD50:250~560mg/kg(大鼠经口);4000mg/kg(大鼠经皮) LC50:
急性中毒:  
慢性中毒:  
亚急性和慢性毒性:  
刺激性:  
致敏性:  
致突变性:  
致畸性:  
致癌性:  
第十二部分:生态学资料
生态毒理毒性:  
生物降解性:  
非生物降解性:  
生物富集或生物积累性:  
第十三部分:废弃处置
废弃物性质:  
废弃处置方法: 根据国家和地方有关法规的要求处置。或与厂商或制造商联系,确定处置方法。
废弃注意事项:  
第十四部分:运输信息
 
 
危险货物编号: 61888
UN编号: 2757
包装标志:  
包装类别:
包装方法: 塑料袋或二层牛皮纸袋外全开口或中开口钢桶;两层塑料袋或一层塑料袋外麻袋、塑料编织袋、乳胶布袋;塑料袋外复合塑料编织袋(聚丙烯三合一袋、聚乙烯三合一袋、聚丙烯二合一袋、聚乙烯二合一袋);塑料袋或二层牛皮纸袋外普通木箱;螺纹口玻璃瓶、塑料瓶、复合塑料瓶或铝瓶外普通木箱;塑料瓶、两层塑料袋或两层牛皮纸袋(内或外套以塑料袋)外瓦楞纸箱。
运输注意事项: 储存于阴凉、通风仓间内。远离火种、热源。防止阳光直射。保持容器密封。应与氧化剂、碱类、食用化工原料分开存放。不可混储混运。搬运时要轻装轻卸,防止包装及容器损坏。分装和搬运作业要注意个人防护。
RETCS号:  
IMDG规则页码:  
第十五部分:法规信息
国内化学品安全管理法规:  
国际化学品安全管理法规:  
第十六部分:其他信息
参考文献: 1.周国泰,化学危险品安全技术全书,化学工业出版社,1997 2.国家环保局有毒化学品管理办公室、北京化工研究院合编,化学品毒性法规环境数据手册,中国环境科学出版社.1992 3.Canadian Centre for Occupational Health and Safety,CHEMINFO Database.1998 4.Canadian Centre for Occupational Health and Safety, RTECS Database, 1989
填表时间: 年月日
填表部门:  
数据审核单位:  
修改说明:  
其他信息: 2
MSDS修改日期: 年月日

甲萘威 海关数据

中国海关编码:2922499916

概述:
2922499916. 甲萘威、地麦威、蜱虱威. 增值税率:17.0%. 退税率:9.0%. 监管条件:ABS(入境货物通关单,出境货物通关单,进出口农药登记证明). 最低关税:6.5%. 普通关税:30.0%
申报要素:
品名, 成分含量, 用途, 乙醇胺及其盐应报明色度, 乙醇胺及其盐应报明包装
监管条件:
A.入境货物通关单B.出境货物通关单S.进出口农药登记证明
检验检疫:
P.进境动植物、动植物产品检疫Q.出境动植物、动植物产品检疫M.进口商品检验
摘要/Summary:
2922499916. VAT:17.0%. Tax rebate rate:9.0%. Supervision conditions:ABS(certificate of inspection for goods inward,certificate of inspection for goods outward,import or export registration certificate for pesticides). MFN tariff:6.5%. General tariff:30.0%

甲萘威 分子结构与计算化学数据

分子结构数据

1、   摩尔折射率:59.03

2、   摩尔体积(cm3/mol):169.9

3、   等张比容(90.2K):440.5

4、   表面张力(dyne/cm):45.1

5、   极化率(10-24cm3):23.40

计算化学数据

1.疏水参数计算参考值(XlogP):无

2.氢键供体数量:1

3.氢键受体数量:2

4.可旋转化学键数量:2

5.互变异构体数量:2

6.拓扑分子极性表面积38.3

7.重原子数量:15

8.表面电荷:0

9.复杂度:230

10.同位素原子数量:0

11.确定原子立构中心数量:0

12.不确定原子立构中心数量:0

13.确定化学键立构中心数量:0

14.不确定化学键立构中心数量:0

15.共价键单元数量:1

甲萘威 下游产品

推荐供应商更多供应商>>

武汉鑫伟烨化工有限公司

产品介绍:
产品名称:西维因 Cas号:63-25-2 纯度:98% 包装信息:25kg,25kg 价格:1.0元 - 1.0元
联系方式:
联系人:郭经理 电话:027-85953558 手机:13377862267

湖北津乐达化工有限公司

产品介绍:
产品名称:西维因 Cas号:63-25-2 纯度:98% 包装信息:1kg,25kg 价格:1.0元 - 1.0元
联系方式:
联系人:刘经理 电话:18086008865 手机:18086008865

湖北广奥生物科技有限公司

产品介绍:
产品名称:西维因 Cas号:63-25-2 纯度:99% 包装信息:1kg铝箔袋/氟化瓶,10kg铝听/纸箱,25kg纸板桶/编织袋/塑料桶,200kg镀锌铁桶/塑料桶,1t吨袋 价格:1.0元 - 1,000.0元
联系方式:
联系人:李经理 电话:027-59223056 手机:15271829679

云南力莲生物有限公司

产品介绍:
产品名称:杀虫剂西维因原料 Cas号:63-25-2 纯度:99% 包装信息:25桶kg 价格:55.0元
联系方式:
联系人:彭强 电话:19912838225 手机:19912830060

湖北万得化工有限公司

产品介绍:
产品名称:西维因 Cas号:63-25-2 纯度:99% 包装信息:1kg铝箔袋/氟化瓶,10kg铝听/纸箱,25kg纸板桶/编织袋/塑料桶,200kg镀锌铁桶/塑料桶,1t吨袋 价格:1.0元 - 1,000.0元
联系方式:
联系人:库薇 电话:027-59210159 手机:15172311821

上海吉至生化科技有限公司

产品介绍:
产品名称:西维因标准溶液 Cas号:63-25-2 纯度:100μg/ml(u=3%,溶剂:丙酮) 包装信息:1ml 价格:178.0元
联系方式:
联系人:胡川丽 电话:021-57520831 手机:15316869680

上海瀚思化工有限公司

产品介绍:
产品名称:西维因 Cas号:63-25-2 纯度:分析标准品,98% 包装信息:250mg 价格:297.6元
联系方式:
联系人:李 电话:021-64806089 手机:17717618050

西格玛奥德里奇

产品介绍:
产品名称:1-萘基-N-甲基氨基甲酸酯 Cas号:63-25-2 纯度:97% 包装信息:g-kg 价格:洽谈
联系方式:
联系人:默克 电话:021-61514946 手机:

湖北江民泰华化工有限公司

产品介绍:
产品名称:西维因 Cas号:63-25-2 纯度:99% 包装信息:25kg,200kg 价格:洽谈
联系方式:
联系人:张经理 电话:13396038321 手机:13396038321

湖北巨胜科技有限公司

产品介绍:
产品名称:西维因 Cas号:63-25-2 纯度: 包装信息:洽谈 价格:洽谈
联系方式:
联系人:孙敏 电话:027-59599240 手机:18702754003